The first step is for patients to see their usual treating doctor, GP or specialist. Your doctor must be an Australian-registered medical practitioner and should have a good understanding of your medical condition(s) including access to your medical records.

Our Xativa^® Hub directory (this is only accessible after you register and verify your account) provides a list of doctors who are familiar with our product. Their location and contact details are provided with their consent so that you may contact them for the purposes of patient access enquiries for medicinal cannabis.

It is the responsibility of the doctor to research and compare products to decide if cannabinoid therapy in which product is suitable for their patients. TGA applications under SAS-B or AP for unregistered medicinal cannabis require documentation confirming the product meets the safety and quality requirements set out in Therapeutic Goods Order No 93 (TGO93). Xativa® meets these requirements.

Any specific product information, including pricing is available only to registered healthcare professionals in Australia.
Your doctor or pharmacist can send product enquiries through:

• Online Enquiry Form
• Call +61 3 9737 4333 or email info@ixsyrinx.com

With the patient’s consent, practitioners can apply for federal and state approval (requirements differ between states) for a medicinal cannabis prescription.

The application must include the following information:

• Patient’s medical condition and relevant medical history
• Documentation outlining medications previously taken unsuccessfully
• A treatment plan and monitoring plan

Who can apply?

This varies depending on the state/territory. Currently in all states except Tasmania, a GP can initiate an application.

Upon receipt of approval from both TGA and State Health Department (for Tasmania only), the script together with the approval(s) will need to be sent, by either the doctor or patient, to a pharmacy. The pharmacy can place orders for products to wholesalers or distributors.

A pharmacist can only dispense product to a patient upon receipt of an original prescription and a copy of the relevant TGA and State Health approval(s).

Determine if your patient is suitable for medicinal cannabis therapy.

TGA resources on this topic can be found here:

https://www.tga.gov.au/publication/guidance-use-medicinal-cannabis-australia-overview

https://www.tga.gov.au/publication/guidance-use-medicinal-cannabis-australia-patient-information

Assess if you are eligible to write an unregistered medicinal cannabis prescription for your patient for submission to the relevant federal and state health authorities.

I am a registered medical doctor in Australia. How do I know if I’m eligible to submit a prescription for Xativa^® to the Federal and State health authorities?

As a registered medical doctor in Australia you are eligible to prescribe unregistered medicinal cannabis to your patients so long as you do not fall into the following category:

• In Tasmania GPs are not permitted to prescribe medicinal cannabis. For Specialists based in Tasmania, state health dept approval needs to be submitted for both Schedule 4 and Schedule 8 unregistered medicinal cannabis products. For more information visit https://www.dhhs.tas.gov.au/psbtas/publications/medical_cannabis/unregistered_medical_cannabis_products_access_flowchart_-_for_health_professionals

In addition, a letter of support from a specialist is required for the following:

• VIC: if the doctor is applying for an indication outside of their regular practice
• WA: for prescribing to patients younger than 16 years of age and those with a history of drug dependence
• ACT: all GPs

Once I have ascertained that I can write a prescription for my patient, how do I go about obtaining TGA approval?

Unregistered medicinal cannabis supply is available through the Special Access (SAS-B) or Authorised Prescriber (AP) Schemes in Australia. Access to these products requires TGA (Therapeutic Goods Administration) approval for individual patients (SAS-B) or classes of patients (AP).

Once TGA SAS approval is received, patient to provide TGA approval with corresponding prescription to any pharmacy of choice.

Doctors & Pharmacists can order product through our webpage: Order Form (accessible only for registered & verified doctor and pharmacist accounts).

A scanned copy of the TGA approval letter (SAS-B or AP) must be provided when placing an order.